Lv11
40 积分 2024-07-03 加入
Haematologic toxicities associated with the addition of bevacizumab in cancer patients
2小时前
求助中
Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial
5个月前
已完结
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer
5个月前
已完结
The split apparent diffusion coefficient sign: A novel magnetic resonance imaging biomarker for cortical pathology with possible implications in autoimmune encephalitis
5个月前
已完结
B7-H3 as a Therapeutic Target in Advanced Prostate Cancer
6个月前
已完结
Deutenzalutamide, an oral deuterated androgen receptor inhibitor, vs placebo for patients with mCRPC who have experienced treatment failure with abiraterone and docetaxel: Results of the HC-1119-04 phase 3 trial
6个月前
已完结
DNA‐repair status should be assessed in treatment‐emergent neuroendocrine prostate cancer before platinum‐based therapy
7个月前
已完结
Treatment Outcomes in Neuroendocrine Prostate Cancer
7个月前
已完结
皖公网安备34019202002308
